Stem Cell Therapy International, Inc. 4
4 · Stem Cell Therapy International, Inc. · Filed Jun 24, 2008
Insider Transaction Report
Form 4
CAO CALVIN
DirectorCEO, President, Chairman
Transactions
- Other
Common Stock
2008-03-25−900,000→ 10,100,000 total(indirect: See footnote)
Footnotes (2)
- [F1]Transfer for legal fees.
- [F2]Disposed of shares originally held in the name of Global Capital Corp. Mr. Cao is deemed the beneficial owner of the shares owned by Global Capital because he is an officer and shareholder of Global Capital.